Select Publications

Book Chapters

Baysari M; Chan J; Carland J; Stocker S; Moran M; Day R, 2018, 'Usability of Reports Generated by a Computerised Dose Prediction Software', in Connecting the System to Enhance the Practitioner and Consumer Experience in Healthcare, IOS Press, Netherlands, pp. 27 - 32, http://dx.doi.org/10.3233/978-1-61499-890-7-27

Day R; pile KD; graham GG; katelaris C, 2016, 'Antimalarial Drugs', in Compendium of Inflammatory Diseases, Springer Basel, Basel, pp. 97 - 101, http://dx.doi.org/10.1007/978-3-7643-8550-7

Day R; graham GG, 2016, 'Coxibs', in Compendium of Inflammatory Diseases, Springer Basel, pp. 1 - 7, http://dx.doi.org/10.1007/978-3-0348-0620-6_22-1

Graham GG; Roberts MS; Day RO; Rainsford KD, 2016, 'Pharmacokinetics and metabolism of the salicylates', in Aspirin and Related Drugs, pp. 97 - 155

Day RO; Graham GG, 2013, 'Non-steroidal anti-inflammatory drugs', in Encyclopedia of Inflammatory Diseases, edn. 6, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Day RO; Graham GG; Williams KM, 2013, 'Propionic acid derivative drugs (Profens)', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Graham GG; Day RO, 2013, 'Salicylates', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Day RO; Williams KM; Graham GG, 2013, 'Urate-lowering therapy: Uricosurics', in Dalbeth N; Peresa-Ruiz F; Schlesinger N (ed.), Gout, Future Medicine Ltd, pp. 174 - 188, http://dx.doi.org/10.2217/ebo.13.104

Pile K; Graham GG; Mahler SM; Day RO, 2011, 'Disease modifying antirheumatic drugs', in Nijkamp FP; Parnham MJ (ed.), Principles of Immunopharmacology, edn. 3, Birkhauser Verlag (Springer), Basel, Switzerland, pp. 585 - 619, http://books.google.com.au/books?id=X0deXiGtcCAC&printsec=frontcover#v=onepage&q&f=false

Baysari MT; Westbrook J; Day RO, 2011, 'Medication decision-making on hospital ward-rounds', in Moen A; Andersen SK; Aarts J; Hurlen P (ed.), Studies in Health Technology and Informatics, IOS Press, Amsterdam, pp. 935 - 939, http://dx.doi.org/10.3233/978-1-60750-806-9-935

Bachmeier CJ; Brooks PM; Day RO; Graham GG; Littlejohn GO; Morand E; Pile K; Williams KM, 2005, 'Disease-modifying anti-rheumatic drugs (DMARD)', in Nijkamp FJ; Parnham MJ (ed.), Principles of Immunopharmacology (2nd Ed), edn. 2nd, Birkhauser Verlag, Basel, pp. 511 - 544

Day RO, 2003, 'Therapy of osteoarthritis', in Scott D; Cope A (ed.), The Year in Rheumatic Disorders 2003, edn. First, Clinical Publishibg Services Ltd, Oxford, United Kingdom, pp. 23 - 34

Day RO; Quinn DE; Williams KK; Handel ML; Brooks PM, 2000, 'Connective tissue and bone disorders', in Melmon and Morrelli`s clinical pharmacology: basic principles in therapeutics, edn. Original, McGrath Hill, New York, pp. 645 - 702

Day RO, 2000, 'Rheumatic Disorders', in Melmon and Morrelli`s clinical pharmacology: basic principles in therapeutics, edn. Original, McGrath Hill, New York, pp. 645 - 702

Day RO; Quinn DI; March LM; Graham GG; Williams KM, 2000, 'Rheumatoid arthritis. New Frontiers in pathogenesis and treatment', in NSAIDs and analgesics, edn. Original, Oxford University Press, Oxford, England, pp. 307 - 328

Brady S; Day RO; Graham GG, 1999, 'Are Intra-Articular steroids as effective?', in Challenges in Rheumatoid Arthritis, edn. Original, Blackwell Science, Oxford, UK, pp. 174 - 189

Bachmeier CJ; Handel ML; Conaghan PG; Williams KM; Graham GG; Brooks PM; Day RO, 1999, 'Disease-modifying antirheumatic drugs', in Nijkamp FP; Parnham MJ (ed.), Principles of Immunopharmacology, edn. 3, Birkhauser Verlag (Springer), Basel, Switzerland, pp. 379 - 403

Graham GG; Milligan MK; Day RO; Williams KM; Ziegler JB, 1998, 'Therapeutic considerations from pharmacokinetics and metabolism: ibuprofen and paracetamol', in Rainsford KD; Powanda MC (ed.), Safety and Efficacy of non-prescription (OTC) analgesics and NSAIDs, Kluwer Academic Publishers, Dordrecht, pp. 77 - 92, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000081416000006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brooks PM; Savdie E; Day RO, 1998, 'Antirheumatic drugs and renal disease', in Rheumatology (2nd Ed), edn. Original, Gower, London, pp. 28 - 29

Brooks PM; Day RO, 1998, 'Arthritis', in Drug Therapy in old age, edn. Original, Wiley & Sons, Chichester UK, pp. 387 - 400

Bachmeier CJ; Handel ML; Conaghan PG; Williams KM; Graham GG; Brooks PM; Day RO, 1998, 'Disease Modifying antirheumatic drugs', in Textbook of Immunopharmacology, edn. 3, Burkhauser, Basel, Switzerland, pp. 183 - 190, http://dx.doi.org/10.1097/00002281-199705000-00003

Day RO, 1998, 'Formulary and Guide to Prescribing (second edition)', in Formulary Guide to Prescribing (2nd Ed), edn. Original, St. Vincent's Hospital, Sydney, Australia, pp. 1 - 445

Yeomans N; Brooks PM; Day RO, 1998, 'Non steroidal anti-inflammatory drugs and peptic ulceration', in Rheumatology (2nd Ed), edn. Original, Gower, London, pp. 27 - 28

Day RO, 1998, 'SARDS', in Rheumatology (2nd Ed), edn. Original, Gower, London, pp. 8.1 - 8.10

Quinn DE; Day RO, 1997, 'Guide to Clinically More Important Drug Interactions.', in Drug Safety, edn. Original, Adis International Limited, Auckland, New Zealand, pp. 1665 - 1700

Day RO, 1997, 'Sulfasalazine.', in In: `The Textbook of Rheumatology`, Edition 5., edn. Original, pp. 741 - 746

Graham GG; Milligan MK; Day RO; Williams KM; Zeig , 1997, 'Therapeutic considerations from pharmacokinetics and metabolism: ibuprofen and paracetamol', in In: `Safety and efficacy of non-prescription (OTC) analgesics, edn. Original, Kluwer Academic Publishers, Great Britain, pp. 77 - 92


Back to profile page